Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study.

Autor: Dubovyk V; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden., Vasileiadis GK; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden., Fatima T; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden., Zhang Y; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden., Kapetanovic MC; Department of Clinical Science, Skåne University Hospital Lund, Lund, Skåne, Sweden., Kastbom A; Department of Biomedical and Clinical Sciences, Linköping University, Linkoping, Sweden., Rizk M; Rheumatology Clinic, Västmanlands Hospital, Vasteras, Sweden., Söderbergh A; Department of Rheumatology, Örebro University Hospital, Orebro, Sweden., Zhao SS; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, The University of Manchester, Manchester, UK., van Vollenhoven RF; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.; Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Hetland ML; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Haavardsholm EA; Centre for treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Nordström D; Department of Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Uusimaa, Finland., Nurmohamed MT; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.; Amsterdam Rheumatology and Immunology center, Amsterdam, The Netherlands., Gudbjornsson B; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland., Lampa J; Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Heiberg MS; Centre for treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway., Sokka-Isler T; Department of Medicine, Jyväskylä Central Hospital, University of Eastern Finland, Jyväskylä, Finland., Gröndal G; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland., Lend K; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.; Rheumatology Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden., Hørslev-Petersen K; Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sonderborg, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark., Uhlig T; Centre for treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Rudin A; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden., Maglio C; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden cristina.maglio@gu.se.

Publikováno v: RMD open [RMD Open] 2024 Apr 04; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 04.

Adipocytokines in Untreated Newly Diagnosed Rheumatoid Arthritis: Association with Circulating Chemokines and Markers of Inflammation.

Autor: Vasileiadis GK; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg, 405 30 Gothenburg, Sweden., Lundell AC; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden., Zhang Y; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg, 405 30 Gothenburg, Sweden., Andersson K; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden., Gjertsson I; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden., Rudin A; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden., Maglio C; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, 413 46 Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg, 405 30 Gothenburg, Sweden.

Publikováno v: Biomolecules [Biomolecules] 2021 Feb 21; Vol. 11 (2). Date of Electronic Publication: 2021 Feb 21.

On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells.

Autor: Ntolkeras G; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Barba C; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Mavropoulos A; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Vasileiadis GK; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Dardiotis E; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Viopolis, 40500, Larissa, Greece., Sakkas LI; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Hadjigeorgiou G; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Viopolis, 40500, Larissa, Greece.; Department of Neurology, University of Cyprus Medical School, Nicosia, Cyprus., Bogdanos DP; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece. bogdanos@med.uth.gr.

Publikováno v: Immunologic research [Immunol Res] 2019 Oct; Vol. 67 (4-5), pp. 310-324.

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Autor: Vasileiadis GK; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Dardiotis E; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece. edar@med.uth.gr., Mavropoulos A; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Tsouris Z; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Tsimourtou V; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Bogdanos DP; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Sakkas LI; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece., Hadjigeorgiou GM; Department of Neurology and Laboratory of Neurogenetics, Faculty of Medicine, School of Health Sciences, University General Hospital of Larissa, University of Thessaly, Biopolis, 40500, Larissa, Greece.; Department of Neurology, Medical School, University of Cyprus, 1678, Nicosia, Cyprus.

Publikováno v: Auto- immunity highlights [Auto Immun Highlights] 2018 Nov 10; Vol. 9 (1), pp. 9. Date of Electronic Publication: 2018 Nov 10.